Abstract
Abstract Rajeshwari Sridhara, PhD, and Robert Temple, MD, who played lead roles in developing the U.S. Food and Drug Administration's draft guidance on enrichment strategies and adaptive design for clinical trials, talk about tends in trial design for oncology drugs.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
